Regulating effects of novel CpG chitosan-nanoparticles on immune responses of mice to porcine paratyphoid vaccines

Biomedical and Environmental Sciences

Volumn 19, Issue 4, 2006, Pages 315-322

  Fu, Man Liang ^a   Ying, San Cheng ^a   Wu, Mei ^a   Li, Hui ^a   Wu, Kai Yuan ^a   Yang, Yi ^a   Zhang, Huan ^a   Cheng, Chi ^a   Wang, Ze Zhou ^a   Wang, Xiu Ying ^a   Lv, Xue Bing ^a   Zhang, Yi Zheng ^a   Gao, Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CNP; CpG oligonucleotide; Immune responses; Mice; Paratyphoid vaccine

Indexed keywords

BACTERIUM ANTIBODY; CHITOSAN; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; IMMUNOGLOBULIN CLASS; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN DERIVATIVE; NANOPARTICLE; OLIGODEOXYRIBONUCLEOTIDE; TYPHOID PARATYPHOID VACCINE;

ANIMAL; ANIMAL SALMONELLOSIS; ARTICLE; BLOOD; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOUSE; PARATYPHOID FEVER; PHYSIOLOGY; SALMONELLA; SALMONELLOSIS; SWINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; CELL PROLIFERATION; CHITOSAN; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN ISOTYPES; INTERLEUKINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; PARATYPHOID FEVER; SALMONELLA; SALMONELLA INFECTIONS, ANIMAL; SWINE; TYPHOID-PARATYPHOID VACCINES;

SALMONELLA; SUIDAE; SUS SCROFA;

EID: 33749384379     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lee S, Hong J, Choi S Y, et al (2004). CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation. J Neuroimmunol 153(1-2), 50-63.
2. Klinman, D M, Currie, D, Gursel, I, et al. (2004). Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199, 201-216.
3. Sandler A D, Chihara H, Kobayashi G, et al (2003). CpG Oligonucleotides Enhance the Tumor Antigen-specific Immune Response of a Granulocyte Macrophage Colony-stimulating Factor-based Vaccine Strategy in Neuroblastoma. Cancer Res 63, 394-399.
4. Dastan T, Turan K (2004). In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells. J Pharm Pharm Sci 7(2), 205-214.
5. Gupta K C, Ravi Kumar M N (2000). Drug release behavior of beads and microgranules of chitosan. Biomaterials 21(11), 1115-1119.
6. Illum L (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res 15, 1326-1331.
7. Janes K A, Calvo P, Alonso M J (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Delivery Rev 47(1), 83-97.
8. Bodmeier R, Chen H G, Paeratakul O (1989). A novel approach to the delivery of micro or nanoparticles. Pharm Res 6(5), 413-417.
9. Battikhi M N (2003). Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan. New Microbiol 26(4), 363-373.
10. Ahmed A M, Furuta K, Shimomura K, et al. (2005). Characterization of a multidrug-resistant isolate of Salmonella Paratyphi B from Japan. J Antimicrob Chemother 10, Epub ahead of print.
11. Shu-Hua Zhao (2004). The prevention and cure experience of young swine paratyphoid. Yunnan Pasturage and Veterinary 2, 38-39.
12. MacFarlane A S, Schwacha M G, Eisenstein T K (1999). In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, Potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infection and Immunity 67(2), 891-898.
13. Mena A, Nichani A K, Popowych Y, et al. (2003). Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells. Immunology 110(2), 250-257.
14. Deng J C, Moore T A, Newstead M W, et al. (2004). CpG oligodeoxynucleotides stimulate protective innate immunity against Pulmonary Klebsiella infection. J Immunol 173, 5148-5155.
15. He B, Qiao X G, Cerutti A (2004). CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173, 4479-4491.
16. Krieg A M (2000). The role of CpG motifs in innate immunity. Curr Opin Immunol 12(1), 35-43.
17. Warren T L, Bhatia S K, Acosta A M, et al. (2000). APC stimulated by CpG oligodeoxynucleotideo Oligodeoxynucleotides enhance activation of MHC class I restricted T cells. J Immunol 165, 6244-6251.
18. Kemp T J, Elzey B D, Griffith, T S. (2003). Plasmacytoid Dendritic Cell-Derived IFN-α Induces TNF-Related Apoptosis-Inducing Ligand/ Apo-2L-Mediated Antitumor Activity by Human Monocytes Following CpG Oligodeoxynucleotide Stimulation. J Immunol 171, 212-218.
19. Meng Z, Shao J, Xiang L (2003). CpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages. Dev Comp Immunol 27(4), 313-321.
20. Cong Y P, Song S S, Bhagat L, et al. (2003). Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells. Biochem Biophys Res Commun 310(4), 1133-1139.
21. Pillarisetty V G, Katz S C, Bleier J I, et al. (2005). Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL-12. J Immunol 174, 2612-2618.
22. Chu R S, Targoni O S, Krieg A M, et al (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186, 1623-1631.
23. Mitsui H, Watanabe T, Saeki H, et al. (2004). Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol 122(1), 95-102.
24. Karpenko L I, Nekrasova N A, Ilyichev A A, et al. (2004). Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen. Vaccine 22(13-14), 1692-1699.
25. Iankov I D, Petrov D P, Mladenov I V, et al (2004). Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis. Microbes Infect 6(10), 901-910.
26. He H, Crippen T L, Farnell M B, et al. (2003). Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells. Dev Comp Immunol 27(6-7), 621-627
27. Dai B, You Z, He P, et al. (2003). Analysis of CpG motifs in endoflagellar gene (flaB2) and expression vector (VR1012) of leptospiral DNA vaccine. Sichuan Da Xue Xue Boo Yi Xue Ban 34(1), 1-4.
28. Krieg A M, Yi A K, Matson S, et al. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
29. Rankin R, Pontarollo R, Gomis S, et al. (2002). CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20(23-24), 3014-3022.
30. Wernette C M, Smith B F, Barksdale Z L, et al. (2002). CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation. Vet Immunol Immunopathol 84(3-4), 223-236.
31. Xing R, Liu S, Guo Z, et al. (2005). Relevance of molecular weight of chitosan and its derivatives and their antioxidant activities in vitro. Bioorg Med Chem 13(5), 1573-1577.
32. Danielsen S, Varum K M, Stokke B T (2004). Structural analysis of chitosan mediated DNA condensation by AFM: influence of chitosan molecular parameters. Biomacromolecules 5(3), 928-936.
33. Huang M, Khor E, Lim L Y (2004). Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 21(2), 344-353.
34. Xu Y M, Du Y M (2003). Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. International Journal of Pharmaceutics 250, 215-226.